Fresenius Claims Edge With US Tocilizumab Biosimilar Approval

German Firm’s Tyenne Rival To Actemra Wins FDA Nod In Both IV And SC Presentations

Two syringes with vials on white background
Tyenne has been approved in both IV And SC formulations • Source: Shutterstock

More from Biosimilars

More from Products